Cumulus Neuroscience
Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.
Domain
cumulusneuro.com
Country
United KingdomIndustry
Health CareEmployees
11-50
Last Funding
$4.8M
Founded
2014
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Cumulus Neuroscience use?+
Cumulus Neuroscience uses 12 technologies including core-js, HubSpot, Isotope.
What industry is Cumulus Neuroscience in?+
Cumulus Neuroscience operates in the Health Care industry.
Where is Cumulus Neuroscience based?+
Cumulus Neuroscience is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026